Article metrics

Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS)

 

Online download statistics by month:

Online download statistics by month: November 2021 to June 2022

AbstractFullPdf
Nov 2021515518242
Dec 202116851687643
Jan 202210461070330
Feb 202210211034399
Mar 2022891898445
Apr 2022574588311
May 2022487495269
Jun 2022442442153
Total666167322792